Pieris-AG

Welcome to Pieris

Pieris is developing Anticalin® product candidates to help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Partnerships

Pieris is always happy to discuss partnering opportunities around its proprietary programs and any new drug discovery partnerships where a partner wants to couple its target know-how with the differentiating features of the Anticalin drug class.

Learn more on how to partner with Pieris »

News

06/30/15

Pieris Pharmaceuticals Prices Public Offering of Common Stock

Read More »
Pieris Pharmaceuticals, Inc. Investor Presentation

Investor Presentation

Pieris Pharmaceuticals, Inc.

Fact Sheet

Stock Info

NASDAQ
PIRS
Change
Volume
Market Cap
Email Alerts